Hong Kong SAR
- Lead the medical affairs tactics and develop brand strategies with cross-function teams for liver disease in the company - Support the medical affairs in the region including Hong Kong, Macau, Singapore, Malaysia and Brunei
- Conducted the site readiness assessment as well as localizing all the relevant documents for launching an early access program for an Alzheimer’s Disease product. - Established the local HCP profile in the disease area and setting up the base for future pre-launch activities (HK position was eliminated in April 2022)
- Deputy of MD - Engaged with internal colleagues (Legal and Compliance, Clinical Operations and Commercial colleagues as appropriate, etc.) in developing, delivering and participating in Medical and/or cross-functional initiatives - Supported the medial team re-structure and led a team with 3 MSLs - Supervised the team in executing the medical tactics along with defined Medical launch/asset strategies and plans, and managed the budget across all TA included, Neuro-immunology, Oncology, Fertility, Endocrinology and General Medicine in Hong Kong
Responsible for the products in Neuro-immunology franchise (DMD for multiple sclerosis) and Oncology franchise (target therapy for mCRC, SCCHN and NSCLC). Participate in strategic planning for launching and existing products.
Responsible for a CV product, engaged with KOLs in multi-specialties (include cardiology, haematology and neurology), participated in strategic planning and rolled out the projects for launching a new product, engaged and initiated 6 study sites in HK for a global observational study.